What is Global Psoriasis Therapeutics Market?
The Global Psoriasis Therapeutics Market is a specialized sector within the broader pharmaceutical industry, focusing on the development and distribution of treatments for psoriasis. Psoriasis is a chronic skin condition characterized by red, itchy, and scaly patches of skin. The market for psoriasis therapeutics is vast and diverse, encompassing a range of treatments from topical creams to systemic drugs and phototherapy. The market is driven by factors such as the increasing prevalence of psoriasis worldwide, advancements in psoriasis treatment, and the growing awareness about the disease and its impact on quality of life. The market is also influenced by the regulatory environment, pricing and reimbursement policies, and the competitive landscape among pharmaceutical companies. The Global Psoriasis Therapeutics Market is a dynamic and evolving field, with new treatments and strategies continually being developed and introduced.
TNF Inhibitors, PDE4 Inhibitors, Interleukin Blockers, Others in the Global Psoriasis Therapeutics Market:
The Global Psoriasis Therapeutics Market includes a variety of treatment options, such as TNF inhibitors, PDE4 inhibitors, interleukin blockers, and others. TNF inhibitors are a type of drug that block the action of TNF, a protein in the body that causes inflammation. These drugs are often used to treat autoimmune diseases like psoriasis. PDE4 inhibitors work by reducing inflammation in the body, and are commonly used in the treatment of psoriasis and psoriatic arthritis. Interleukin blockers, on the other hand, are a newer class of drugs that work by targeting specific proteins in the immune system to help reduce inflammation and slow the overproduction of skin cells that is characteristic of psoriasis. Other treatments in the market include topical treatments, systemic medications, and phototherapy. Each of these treatments has its own set of advantages and disadvantages, and the choice of treatment often depends on the severity of the psoriasis, the patient's overall health, and their personal preferences.
Oral, Parenteral, Topical in the Global Psoriasis Therapeutics Market:
The Global Psoriasis Therapeutics Market also encompasses various methods of drug administration, including oral, parenteral, and topical routes. Oral administration, which involves swallowing a pill or liquid, is often the first line of treatment for mild to moderate psoriasis. Parenteral administration, which includes injections and infusions, is typically used for moderate to severe psoriasis, or when oral medications are not effective. Topical treatments, which are applied directly to the skin, are commonly used for mild psoriasis, or in combination with other treatments for more severe cases. The choice of administration method depends on a variety of factors, including the type and severity of the psoriasis, the specific drug being used, and the patient's overall health and lifestyle.
Global Psoriasis Therapeutics Market Outlook:
Looking at the market outlook, the global pharmaceutical market is projected to reach a value of 1475 billion USD in 2022, growing at a compound annual growth rate (CAGR) of 5% over the next six years. This growth is driven by a variety of factors, including the increasing prevalence of chronic diseases, advancements in medical technology, and the growing global population. In comparison, the chemical drug market is expected to grow from 1005 billion USD in 2018 to 1094 billion USD in 2022. This growth is largely driven by the increasing demand for generic drugs, the development of new chemical entities, and the expansion of the pharmaceutical industry in emerging markets.
| Report Metric | Details |
| Report Name | Psoriasis Therapeutics Market |
| CAGR | 5% |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Astellas Pharma Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, F. Hofffmann-La Roche, GlaxoSmithKline plc, Merck & Co., Inc., Valeant Pharmaceuticals International, Inc., Biocon Limited, Eli Lilly and Company, G & W Laboratories Inc. |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
